ilmscore | Innova Captab Limited | IPO Summary | CA Rachana Ranade

Innova Captab Limited | IPO Summary | CA Rachana Ranade

Published: 2023-12-22
Status: Available | Analyzed

Predictions from this Video

Total: 6
Correct: 0
Incorrect: 0
Pending: 6
Unrated: 0
Prediction
Topic
Status
Company management intends to increase focus on domestic branded generics due to higher profit margins.
"management is saying they're wanting to focus more and more on domestic branded generics why profit margin is higher than this"
Innova Captab Limited IPO
Pending
The Indian pharmaceutical market is expected to grow at a CAGR of 9-10% from 2023 to 2028.
"Indian market...if I check the cagr 18 to 23 cagr was around 9% and again it is estimated to grow at 9 to 10% only from 23 to 28"
Indian Pharmaceutical Market Growth
Pending
Innova Captab Limited is planning to open a new manufacturing facility in Jammu and Kashmir, which will be funded by debt.
"they are wanting to open a new manufacturing facility at Jammu and Kashmir and that is the reason why to do that capex they need money and that is the reason why they have taken debt"
Innova Captab Limited - Expansion
Pending
The new manufacturing facility in Jammu is motivated by the availability of fiscal incentives, including GST reimbursement and input tax credit.
"they want to avail fiscal incentive. what is the incentive they'll get? Reimbursement of GST paid through cash and ITC, ITC is basically an input tax credit it is the main motive to open the facility in Jammu"
Innova Captab Limited - Tax Benefits
Pending
For the three months ending June 30, 2023, 100% of the company's raw material was imported from China.
"for the 3 months ended 30th June 2023 100%!!! 100% of the raw material was imported from China"
Imported Raw Materials from China
Pending
The Innova Captab Limited IPO was subscribed 1.03 times within the first half day of its opening.
"IPO has already been subscribed 1.03 times within first half day of opening"
Innova Captab Limited IPO Subscription
Pending